Center
for Drug Evaluation &
Research (CDER) News |
Center
for Biologics Evaluation & Research (CBER) |
Center
for Device &
Radiological
Health (CDRH) |
Federal Register -
Meetings, Notices, & Rule Changes |
July
17, 2008
-
FDA
updates healthcare professionals
about recent changes made to the
Boxed Warning, Warnings, and
Contraindications sections of
the prescribing information for
micro-bubble contrast agents.
Drug Information
-
New
and Generic Drug Approvals
-
Roxane Laboratories informs
healthcare professionals of the
recall of two lots of Sodium
Polystyrene Sulfonate
Suspension, a product used to
treat hyperkalemia.
MedWatch Safety Information
July
16, 2008
-
Drugs@FDA Downloadable Data
Files
(updated)
-
New
Drug Application (NDA) and
Biologic License Application (BLA)
Efficacy Supplements Approved
(CY 2008)
(updated)
-
New
and Generic Drug Approvals
-
FazaClo ODT
(clozapine) Orally
Disintegrating Tablets,
Beckloff Associates, Inc.,
Labeling Revision
-
Meloxicam
Tablets, Beijing
Double-Crane Pharmaceutical
Co., Ltd., Supplement
-
Starlix
(nateglinide) Tablets,
Novartis Pharmaceuticals
Corp., Labeling Revision
-
SYMBICORT
(budesonide and formoterol
fumarate dihydrate)
Inhalation Spray,
AstraZeneca Pharmaceuticals,
Labeling Revision
-
Obtaining an IND for Estriol
July
15, 2008
-
CDER Organization Charts [HTML]
[PDF]
(updated)
-
Medical, Statistical, and
Clinical Pharmacology Reviews of
Pediatric Studies
(updated)
-
New
and Generic Drug Approvals
-
Levoleucovorin
(levoleucovorin calcium)
I.V. Powder, Spectrum
Pharmaceuticals, Inc.,
Labeling Revision
-
Prandin
(repaglinide) Tablets, Novo
Nordisk, Inc., Labeling
Revision
-
Synthroid
(levothyroxine sodium)
Tablets, Abbott
Laboratories, Labeling
Revision
July
14, 2008
-
Genentech informs healthcare
professionals of reports of
several cases of
microangiopathic hemolytic
anemia (MAHA) in patients with
solid tumors receiving Avastin
in combination with sunitinib
malate.
MedWatch Safety Information
-
Guidance for Industry: Current
Good Manufacturing Practice for
Phase 1 Investigational Drugs [PDF]
-
New
and Generic Drug Approvals
-
Avandia
(rosiglitazone maleate)
Tablets, GlaxoSmithKline,
Efficacy Supplement with
Clinical Data to Support
CDER Drug Links
|
CBER Links
|
| July 17, 2008 |
 |
FDA / NHLBI / NSF Workshop on Computer Methods for Cardiovascular Devices, March 18-19, 2008 (Video Added)  |
| |
| July 16, 2008 |
 |
Summary Information for: EVOLENCE Collagen Filler  |
 |
Guidance for Industry and FDA Staff - Class II Special Controls Guidance Document: Bone Sonometers   |
 |
Orthopaedic and Rehabilitation Devices Panel Advisory Meeting, July 15, 2008 - Agenda, Roster, Briefing, Questions, Brief Summary  |
 |
PMA Final Decisions for June 2008  |
| |
| July 14, 2008 |
 |
FDA Preliminary Public Health Notification: Possible Malfunction of Electronic Medical Devices Caused by Computed Tomography (CT) Scanning  |
| |
|
|
|
Medical Device Links
|
Weekly
Rule Changes
Part(s)
Drug
GMPs 210 -
Device
892 |
|
Friday,
July 18, 2008 |
|
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals,
4136041361 [E816447]
[TEXT] [PDF]
Compliance Policy Guide Sec.
540.575:
Fish Fresh and
Frozen Adulteration
Involving Decomposition (CPG
7108.05); Withdrawal,
41361 [E816456]
[TEXT] [PDF]
Draft Compliance Policy
Guide Sec. 540.370:
Fish and Fishery
Products Decomposition;
Availability,
4136141362 [E816453]
[TEXT] [PDF]
Meetings:
Animal Models for
the Treatment of Acute
Radiation Syndrome,
41362 [E816461]
[TEXT] [PDF]
Rapid Methods for
Detecting Mycoplasma
Contamination in the
Manufacture of Vaccines,
Including Pandemic Influenza
Vaccines, and Other
Biological Products,
4136241363 [E816459]
[TEXT] [PDF]
Small Entity Compliance
Guides:
Food Labeling;
Nutrient Content Claims;
Definition for High Potency
and Definition of
Antioxidant,
4136341364 [E816448]
[TEXT] [PDF]
|
|
Thursday,
July 17, 2008 |
|
RULES
Medical Devices; Radiology
Devices; Reclassification of
Bone Sonometers,
4096740970 [E816354]
[TEXT] [PDF]
NOTICES
Guidance for Industry:
Safety, Efficacy, and
Pharmacokinetic Studies to
Support Marketing of Immune
Globulin Intravenous (Human)
as Replacement Therapy for
Primary Humoral Immunod,
4108741088 [E816395]
[TEXT] [PDF]
Medical Devices and
Radiology Devices:
Class II
Special Controls Guidance
Document: Bone Sonometers
Guidance for
Industry and Food and Drug
Administration Staff,
4108841089 [E816094]
[TEXT] [PDF]
Small Entity Compliance
Guide:
Standard of
Identity for White
Chocolate; Availability,
41090 [E816394]
[TEXT] [PDF]
Small Entity Compliance
Guide; Availability:
Final Rule
Declaring Dietary
Supplements Containing
Ephedrine Alkaloids
Adulterated Because They
Present an Unreasonable
Risk,
4108941090 [E816396]
[TEXT] [PDF]
|
|
Wed.,
July 16, 2008 |
|
NONE
|
|
Tuesday,
July 15, 2008 |
|
RULES
Current Good Manufacturing
Practice and Investigational
New Drugs Intended for Use
in Clinical Trials,
4045340463 [E816011]
[TEXT] [PDF]
NOTICES
Determination:
SANOREX (Mazindol) Tablets 1
and 2 Milligrams Were Not
Withdrawn From Sale for
Reasons of Safety or
Effectiveness,
4058240583 [E815998]
[TEXT] [PDF]
Global Harmonization Task
Force, Study Groups 1 and 3
Proposed and Final
Documents; Availability,
4058340584 [E816000]
[TEXT] [PDF]
Guidance for Industry:
Current Good
Manufacturing Practice for
Phase 1 Investigational
Drugs; Availability,
4058440585 [E816002]
[TEXT] [PDF]
|
|
Monday,
July 14, 2008 |
|
NONE
|
|
|
|




EU - US - ICH GMP
Combination Product
handbook |
|
US GMP Training Booklet |
|
Std. GMPs
- Parts 11, 210, 211, 820 &
ICH Q7 |
|
Med. Device - 11, 50,
54, 56, 807, 812, 814, 820,
510k/PMA |
|
Clinical GCP - Parts 11,
50, 54, 56, 312, 314 & ICH
E2A & E6 |
|
Multi-US GMPs 11, 58,
210/211, 600, 601, 610
& 820 |
|
Parts 210/211 - Drug
GMPs |
|
>210/211
with Part 11 |
|
>210/211
with Part 820 |
|
>210/211
with Parts 820 & 11 |
|
>210/211
w/ Keyword Index |
Part 820
Quality Systems Regs
|
|
Part 58 - GLP Good
Lab. Practice |
Part 11
- Electronic Records w/
Scope and Applications
|
GLP 2 11 & 58 - Part 11
& 58
|
PDMA 11,
203 & 205 - Prescription
Drug Marketing
|
|
|
11
& 820 Electronic Record
and Quality Systems
|
|
|
|
The e-Newsletter of
What's New with CDER, CDRH & CBER
Distributed by the worlds
leader in Federal Regulations,
GMP Publications, Inc. & FDA.COM
Tel: 866-GXPNews (or 856-810-7331) Fax: 856-810-7339
http://www.gmppublications.com /
http://www.fda.com
John Cuspilich, Sr. Editor, GXPNews
If you would
like to advertise in this eNewsletter, call
856-810-1825
|